Analysts' Actions: HOLX COST FDX GOGO INTC


Clean Harbors was downgraded at Credit Suisse to neutral from outperform. Estimates were also cut, given higher cyclicality and capital intensity, Credit Suisse said. $62 price target. 

Costco was downgraded at UBS to neutral from buy. Valuation call, UBS said. $124 price target.

Domino's Pizza was upgraded to buy at TheStreet Ratings.

EQT was upgraded at Stifel Nicolaus to buy from hold. $100 price target. Stock has pulled back to an attractive level and the company has potential near-term catalysts, Stifel Nicolaus said.

FedEx was downgraded at Cowen to market perform from outperform. Valuation call, based on a $136 price target, Cowen said. 

Gogo was downgraded at UBS to neutral from buy. Valuation call, UBS said. $26 price target.

Hologic was downgraded at William Blair to market perform. Still waiting for the business to bottom out, William Blair said. 

Hologic was downgraded at Canaccord Genuity to hold. $19 price target. Fundamentals continue to deteriorate, Canaccord Genuity said. 

Hologic was downgraded at RBC Capital to Sector Perform from Top Pick. $21 price target. Weaker legacy sales are hurting overall growth, RBC Capital said.

Heartland Payment was downgraded at Robert Baird to neutral from outperform. Valuation call, as the company has exceeded the S&P 500 by 21% so far this year, Robert Baird said. 

Intel was downgraded at MKM Partners to neutral. PCs continue to weigh on revenue, and there are few catalysts to drive the stock price, MKM Partners said. $12 price target.

Innospec was downgraded at Keybanc to hold from buy. Valuation call, with the stock within 5% of the previous price target, Keybanc said.

Qualcomm was initiated at Jefferies with a buy rating. QTL chip revenue expected to shift to smartphones, Jefferies said. $80 price target.

Rovi was upgraded at Pacific Crest to sector perform. Stock is pricing in risks around CE pricing, Pacific Crest said.

Ruby Tuesday was downgraded to sell at TheStreet Ratings.

was downgraded at Piper Jaffray to underweight from overweight. $20 price target. FDA reversed view on the company's Eteplirsen filing, Piper Jaffray said. 

Symantec was downgraded at Macquarie to neutral from outperform. $24 price target. Company continues to see executive turnover, Macquarie said. 

Trimble was initiated with a buy rating at MKM Partners. $37 price target. See upside to consensus earnings expectations, MKM Partners said.

Stock Comments / EPS Changes price target was raised at Pacific Crest to $60. Company can likely exceed conservative guidance, Pacific Crest said. Outperform rating.

Follow TheStreet on Twitter and become a fan on Facebook.

EXCLUSIVE OFFER: See inside Jim Cramer’s multi-million dollar charitable trust portfolio to see the stocks he thinks could be potentially HUGE winners. Click here to see his holdings for FREE.

View Comments (0)